PRDM1 Drives Chemoradiotherapy-associated Enrichment of Adaptive NK Cells in Cervical Cancer
Meng Wan, Tangwu Zhong, Wenyang Shi, Jianyu Shen, Wei Zhang, Yizhe Sun
This study identifies PRDM1 as a key regulator of adaptive NK cell enrichment and functional activation in cervical cancer following chemoradiotherapy.
bioRxiv · Feb 1, 2026 · PreprintImmunology